Bookmark

Add to MyYahoo RSS

Amgen News

News on Amgen (Ticker: AMGN) continually updated from thousands of sources around the net.

6 hrs ago | Pacific Business Times

Atara Biotherapeutics angles for $92M, but jobs are scarce

Atara is among a new breed of "virtual" biotech startups. Such firms operate with barebones staff and outsource research and manufacturing operations to contract organizations.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Thousand Oaks, CA, Westlake Village (Thousand Oaks, CA), Westlake Village, CA, Celgene

Thu Aug 28, 2014

Applied Clinical Trials

Amgen Submits Biologics License Application For Novel Investigational ...

Evolocumab is an investigational fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 , a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol , or "bad" cholesterol, from the blood.1 The BLA for evolocumab contains data from approximately 6,800 patients, including more than ... (more)

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Genetics

Wed Aug 27, 2014

Applied Clinical Trials

FDA Grants Amgen Priority Review Designation For Ivabradine For The...

Ivabradine is an oral drug that inhibits the I f current in the sinoatrial node, the body's cardiac pacemaker.1 Ivabradine works to slow the heart rate without negative effects on myocardial contractility or ventricular repolarization.1 Heart failure is a common condition that affects approximately 26 million worldwide, including approximately 5.1 ... (more)

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Marketing

Seeking Alpha

Why Amgen Stock Is A Long-Term Investment Opportunity

Amgen Inc. will continue to benefit from the growing demand for its products, and from its top-quality pipeline that should sustain long-term growth.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Enbrel, Etanercept (generic), Financial Markets

Mon Aug 25, 2014

AmericanBankingNews.com

Amgen Reaches New 12-Month High at $134.93

Amgen 's share price hit a new 52-week high during mid-day trading on Monday , Stock Ratings Network.com reports.

Comment?

Related Topix: Biotech, Amgen, Medicine, Healthcare Industry

Thu Aug 21, 2014

Seeking Alpha

Puma Biotechnology: Who Are They? What Happened? And, Where Are They Going?

Puma Biotech, a small development stage biopharmaceutical company, recently announced positive results in one of their Phase III trials.

Comment?

Related Topix: Medicine, Cancer, Health, Healthcare Law, Law, Breast Cancer, Pfizer, Excaliard Pharmaceuticals, Biotech, Healthcare Industry

Seeking Alpha

Amgen Has Yet To Reach Its Potential, Despite Strong Gains

With shares of Amgen trading at near 52-week highs, investors are getting nervous about the next couple of quarters.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Johnson and Johnson, Pfizer, GlaxoSmithKline

Mon Aug 18, 2014

Sys-Con Media

Amgen Announces Positive Top-Line Results From Second Phase 3 Study...

The primary endpoint was the proportion of patients with > 30 percent reduction from baseline in parathyroid hormone levels during an Efficacy Assessment Phase defined as the period between weeks 20 and 27. These results follow the recent announcement of positive data from a prior placebo-controlled Phase 3 study of AMG 416 which was similar in ... (more)

Comment?

Related Topix: Biotech, Amgen, Medicine, Healthcare Industry

Thu Aug 14, 2014

Forbes.com

Thursday Sector Leaders: Utilities, Healthcare

The best performing sector as of midday Thursday is the Utilities sector, higher by 0.9%.

Comment?

Related Topix: Pinnacle West Capital Corporation, Energy, Duke Energy, Financial Markets, Biotech, Medicine, Amgen, Healthcare Industry, Perrigo

AmericanBankingNews.com

Amgen Reaches New 52-Week High at $132.52

Amgen reached a new 52-week high on Thursday , Analyst Ratings Network.com reports.

Comment?

Related Topix: Biotech, Amgen, Medicine, Healthcare Industry

Forbes.com

Thursday's ETF Movers: BBH, GXC

In trading on Thursday, the Biotech ETF is outperforming other ETFs, up about 1.4% on the day.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Alkermes, Financial Markets

InvestorIdeas.com

Biotech News Alert: GenSpera (OTCQB:GNSZ) to Present at Rodman &...

August 14, 2014 GenSpera, Inc. , a leader in developing prodrug therapeutics for the treatment of cancer, announces it will be presenting at the Rodman & Renshaw 16th Annual Global Investment Conference.

Comment?

Related Topix: Investment Banking, Financial Services, Rodman and Renshaw, Manufacturing, Bayer HealthCare, Chemicals, Startups, Onyx Pharmaceuticals

Wed Aug 13, 2014

Freshnews

Amgen Issues Voluntary Recall of AranespA (darbepoetin alfa) (500...

Amgen initiated a voluntary recall on June 26, 2014 for nine packaged lots of Aranesp prefilled syringes from non-U.S. distributors, wholesalers and a number of hospital pharmacies due to the potential presence of cellulose and/or polyester particles observed in a small number of syringes during a routine quality examination.

Comment?

Related Topix: Biotech, Amgen, Healthcare Industry, Food and Drug Administration

Applied Clinical Trials

Amgen Announces Top-Line Results From Phase 3 Focus Trial Of...

The 315-patient, open-label study evaluated single-agent Kyprolis for Injection compared to an active control regimen of low-dose dexamethasone, or equivalent corticosteroids, plus optional cyclophosphamide in patients with relapsed and advanced refractory multiple myeloma.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Amgen, Healthcare Industry, Startups, Onyx Pharmaceuticals, Cyclophosphamide (generic), Cytoxan

Tue Aug 12, 2014

Forbes.com

Amgen Popular Amongst Latest 13F Filers

At Holdings Channel , we have reviewed the latest batch of the 43 most recent 13F filings for the 06/30/2014 reporting period, and noticed that Amgen was held by 16 of these funds.

Comment?

Related Topix: Biotech, Amgen, Medicine, Healthcare Industry, Financial Markets

Mon Aug 11, 2014

AmericanBankingNews.com

Amgen Sees Unusually High Options Volume

Amgen saw unusually large options trading on Monday. Stock traders acquired 23,340 call options on the company, AnalystRatings.Net reports.

Comment?

Related Topix: Biotech, Amgen, Medicine, Healthcare Industry

Sat Aug 09, 2014

AmericanBankingNews.com

Amgen Given Average Recommendation of "Buy" by Brokerages

Amgen has been given an average recommendation of "Buy" by the twenty brokerages that are covering the company, AnalystRatings.Net reports .

Comment?

Related Topix: Biotech, Amgen, Medicine, Healthcare Industry

Fri Aug 08, 2014

Sys-Con Media

Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals,...

To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

Comment?

Related Topix: Stratasys, Computers, Computer-Aided Design, Manufacturing and Engineering, Software, Biotech, Isis Pharmaceuticals, Medicine, Healthcare Industry, Amgen, Financial Services, Discover Financial Services

Wed Aug 06, 2014

USA Today

Congrats on a great quarter - now, you're fired

Last week Amgen, one of the USA's biggest biotechnology companies, reported a sensational quarter.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Science / Technology, Fremont, CA

Tue Aug 05, 2014

Seeking Alpha

Aspire Data A Big Plus For Amgen And Celgene

Strong interim data Yesterday, Amgen released data from a planned interim analysis of the Aspire study that could lead to a significant sales boost.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Celgene, Startups, Onyx Pharmaceuticals, Johnson and Johnson

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••